Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Unknown 1 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hemangioma 3 Prostatic Neoplasms 2 Uterine Cervical Neoplasms 1 Melanoma 1 Hemangioma, Cavernous, Central Nervous System 1 Breast Neoplasms 1 Anxiety Disorders 1

Interventions

Trastuzumab 78 Capecitabine 59 Cyclophosphamide 54 Paclitaxel 52 Docetaxel 50 Letrozole 44 Fulvestrant 43 Lapatinib 34 Doxorubicin 31 Carboplatin 31 Vinorelbine 30 Bevacizumab 29 Anastrozole 28 pembrolizumab 26 exemestane 24 Tamoxifen 23 Gemcitabine 22 Radiotherapy 21 Albumin-Bound Paclitaxel 19 Taxes 17 Everolimus 17 Epirubicin 15 pertuzumab 13 Ado-Trastuzumab Emtansine 13 130-nm albumin-bound paclitaxel 13 palbociclib 12 Magnetic Resonance Spectroscopy 12 liposomal doxorubicin 11 atezolizumab 11 Filgrastim 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Breast Neoplasms × Propranolol × Clear all

NCT02596867 2018-03-01

NPBC

Texas Tech University Health Sciences Center, El Paso

Phase 2 Terminated

2 enrolled 5 charts

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡